NBS stock price is on the rise again after NeoStem Inc. (NYSE MKT: NBS) was upgraded by analysts at WBB Securities from a “buy” to a “strong-buy“. The stem cell stock appears to be closing in on its 9th positive trading session ot of the ...
February was a tough month for biotech stocks researching stem cells for the treatment and cure of diseases. TickerSpy’s Stem Cell Stocks Index (RXSTM) has slipped nearly 13% since early February being outperformed by the S&P 500 by close to 17% during that time.
Four particular stem cell stocks, all cheap stocks under 5 including 2 penny stocks, should ...
Continue Reading →“Be fearful when others are greedy, and be greedy when others are fearful.” – Warren Buffett
NeoStem, Inc.(AMEX:NBS) announced today that its Chief Medical Officer, the lead investigator for its PreSERVE Phase 2 clinical trial for AMR-001 for preservation of heart function in post ...
Continue Reading →